T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
LKQ Corp
LKQ
$6.25B
| $15.2M | ﹤0.01% |
380,146
+1,348
| +0.4% | +$55.5K |
|
1052
Dolby
DLB
$5.84B
| $15M | ﹤0.01% |
195,615
+141,593
| +262% | +$10.5M |
|
1053
WEX
WEX
$6.48B
| $14.9M | ﹤0.01% |
70,987
-1,251
| -2% | -$233K |
|
1054
Teva Pharmaceuticals
TEVA
$42.6B
| $14.9M | ﹤0.01% |
825,431
+571,302
| +225% | +$10M |
|
1055
Freshpet
FRPT
$3.48B
| $14.9M | ﹤0.01% |
108,708
-462,322
| -81% | -$60.5M |
|
1056
Tapestry
TPR
$25.9B
| $14.9M | ﹤0.01% |
316,151
+5,364
| +2% | +$221K |
|
1057
Vital Farms
VITL
$495M
| $14.8M | ﹤0.01% |
422,622
+409,762
| +3,186% | +$14.5M |
|
1058
EPR Properties
EPR
$4.7B
| $14.6M | ﹤0.01% |
298,513
+232,330
| +351% | +$10.6M |
|
1059
Illumina
ILMN
$29.1B
| $14.6M | ﹤0.01% |
112,068
-584
| -0.5% | -$72K |
|
1060
Toll Brothers
TOL
$13.9B
| $14.6M | ﹤0.01% |
94,299
+10,324
| +12% | +$1.4M |
|
1061
Henry Schein
HSIC
$10.1B
| $14.5M | ﹤0.01% |
198,983
+87
| +0% | +$6.03K |
|
|
FOLD
1062
DELISTED
Amicus Therapeutics
FOLD
| $14.3M | ﹤0.01% |
1,341,921
-48,126
| -3% | -$524K |
|
1063
Workiva
WK
$3.7B
| $14.2M | ﹤0.01% |
179,552
-215,749
| -55% | -$16.2M |
|
1064
BWX Technologies
BWXT
$15.8B
| $14.2M | ﹤0.01% |
130,235
+4,187
| +3% | +$416K |
|
|
OS
1065
DELISTED
OneStream Inc
OS
| $14.1M | ﹤0.01% |
+415,521
| New | +$12.2M |
|
1066
Affiliated Managers Group
AMG
$9.57B
| $14.1M | ﹤0.01% |
79,217
+2,837
| +4% | +$482K |
|
1067
Match Group
MTCH
$8.4B
| $14M | ﹤0.01% |
370,937
-14,788
| -4% | -$517K |
|
1068
MGM Resorts International
MGM
$11.1B
| $14M | ﹤0.01% |
357,174
-184,274
| -34% | -$7.29M |
|
|
AUTL
1069
Autolus Therapeutics
AUTL
$564M
| $13.9M | ﹤0.01% |
3,841,502
-572,585
| -13% | -$2.28M |
|
1070
Solventum
SOLV
$14.5B
| $13.9M | ﹤0.01% |
199,772
-292
| -0.1% | -$17.6K |
|
1071
Novartis
NVS
$290B
| $13.9M | ﹤0.01% |
120,721
+113,634
| +1,603% | +$12.9M |
|
1072
Avantor
AVTR
$9.37B
| $13.9M | ﹤0.01% |
536,731
-12,545
| -2% | -$308K |
|
1073
First Advantage
FA
$3.61B
| $13.9M | ﹤0.01% |
699,447
+683,139
| +4,189% | +$12.2M |
|
1074
Pinnacle West Capital
PNW
$12.2B
| $13.8M | ﹤0.01% |
156,029
+1,000
| +0.6% | +$85.4K |
|
1075
Impinj
PI
$5.49B
| $13.8M | ﹤0.01% |
63,538
+48,771
| +330% | +$8.27M |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.